KR20150096237A - Composition containing fermented material of pear and ginger for immune activity - Google Patents
Composition containing fermented material of pear and ginger for immune activity Download PDFInfo
- Publication number
- KR20150096237A KR20150096237A KR1020140017423A KR20140017423A KR20150096237A KR 20150096237 A KR20150096237 A KR 20150096237A KR 1020140017423 A KR1020140017423 A KR 1020140017423A KR 20140017423 A KR20140017423 A KR 20140017423A KR 20150096237 A KR20150096237 A KR 20150096237A
- Authority
- KR
- South Korea
- Prior art keywords
- ginger
- pear
- fermented product
- fermentation broth
- composition
- Prior art date
Links
- 235000006886 Zingiber officinale Nutrition 0.000 title claims abstract description 91
- 235000008397 ginger Nutrition 0.000 title claims abstract description 91
- 241000234314 Zingiber Species 0.000 title claims abstract description 90
- 239000000203 mixture Substances 0.000 title claims abstract description 58
- 235000014443 Pyrus communis Nutrition 0.000 title claims abstract description 37
- 239000000463 material Substances 0.000 title description 2
- 230000005965 immune activity Effects 0.000 title 1
- 238000000855 fermentation Methods 0.000 claims abstract description 49
- 230000004151 fermentation Effects 0.000 claims abstract description 49
- 235000013305 food Nutrition 0.000 claims abstract description 24
- 239000004480 active ingredient Substances 0.000 claims abstract description 18
- 240000001987 Pyrus communis Species 0.000 claims description 34
- 241000208340 Araliaceae Species 0.000 claims description 17
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims description 17
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 17
- 235000008434 ginseng Nutrition 0.000 claims description 17
- 230000036541 health Effects 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 9
- 235000013376 functional food Nutrition 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 7
- 238000005119 centrifugation Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 230000002519 immonomodulatory effect Effects 0.000 claims description 2
- 230000036039 immunity Effects 0.000 abstract description 21
- 230000002708 enhancing effect Effects 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 10
- 239000008194 pharmaceutical composition Substances 0.000 abstract description 9
- 239000000284 extract Substances 0.000 abstract description 5
- 230000036737 immune function Effects 0.000 abstract description 5
- 241000220324 Pyrus Species 0.000 abstract description 4
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 abstract description 3
- 102000004127 Cytokines Human genes 0.000 abstract description 3
- 108090000695 Cytokines Proteins 0.000 abstract description 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract description 3
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 abstract description 3
- 210000001541 thymus gland Anatomy 0.000 abstract description 3
- 235000013311 vegetables Nutrition 0.000 abstract description 3
- 229940002508 ginger extract Drugs 0.000 abstract description 2
- 235000020708 ginger extract Nutrition 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 210000000265 leukocyte Anatomy 0.000 abstract description 2
- 235000021017 pears Nutrition 0.000 abstract 1
- 239000000047 product Substances 0.000 description 52
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000013361 beverage Nutrition 0.000 description 12
- 235000019634 flavors Nutrition 0.000 description 11
- 208000026278 immune system disease Diseases 0.000 description 10
- 150000001720 carbohydrates Chemical group 0.000 description 7
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 239000004615 ingredient Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 239000000546 pharmaceutical excipient Substances 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 5
- 229930006000 Sucrose Natural products 0.000 description 5
- 229940127121 immunoconjugate Drugs 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000005720 sucrose Substances 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 239000000427 antigen Substances 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 210000004195 gingiva Anatomy 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 4
- 239000002562 thickening agent Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 206010010356 Congenital anomaly Diseases 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 206010012438 Dermatitis atopic Diseases 0.000 description 3
- 239000004375 Dextrin Substances 0.000 description 3
- 229920001353 Dextrin Polymers 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 239000004386 Erythritol Substances 0.000 description 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 206010057190 Respiratory tract infections Diseases 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 201000008937 atopic dermatitis Diseases 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- -1 citric acid Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000019425 dextrin Nutrition 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 3
- 235000019414 erythritol Nutrition 0.000 description 3
- 229940009714 erythritol Drugs 0.000 description 3
- 210000000987 immune system Anatomy 0.000 description 3
- 239000003022 immunostimulating agent Substances 0.000 description 3
- 230000003308 immunostimulating effect Effects 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 235000015067 sauces Nutrition 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 229960005486 vaccine Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 208000032467 Aplastic anaemia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- 239000001512 FEMA 4601 Substances 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 239000004378 Glycyrrhizin Substances 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 229920002230 Pectic acid Polymers 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 239000000605 aspartame Substances 0.000 description 2
- 235000010357 aspartame Nutrition 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 229960003438 aspartame Drugs 0.000 description 2
- 208000010928 autoimmune thyroid disease Diseases 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000014171 carbonated beverage Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000084 colloidal system Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 229940097362 cyclodextrins Drugs 0.000 description 2
- 150000002016 disaccharides Chemical class 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 229960001438 immunostimulant agent Drugs 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 230000015788 innate immune response Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 206010025135 lupus erythematosus Diseases 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 230000003446 memory effect Effects 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 2
- 239000010318 polygalacturonic acid Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 235000019203 rebaudioside A Nutrition 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 229940081974 saccharin Drugs 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- GOZMBJCYMQQACI-UHFFFAOYSA-N 6,7-dimethyl-3-[[methyl-[2-[methyl-[[1-[3-(trifluoromethyl)phenyl]indol-3-yl]methyl]amino]ethyl]amino]methyl]chromen-4-one;dihydrochloride Chemical compound Cl.Cl.C=1OC2=CC(C)=C(C)C=C2C(=O)C=1CN(C)CCN(C)CC(C1=CC=CC=C11)=CN1C1=CC=CC(C(F)(F)F)=C1 GOZMBJCYMQQACI-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 206010049153 Allergic sinusitis Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000014181 Bronchial disease Diseases 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 235000002568 Capsicum frutescens Nutrition 0.000 description 1
- 206010010744 Conjunctivitis allergic Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 206010018366 Glomerulonephritis acute Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 241000287420 Pyrus x nivalis Species 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 206010039094 Rhinitis perennial Diseases 0.000 description 1
- 208000036284 Rhinitis seasonal Diseases 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 102000011842 Serrate-Jagged Proteins Human genes 0.000 description 1
- 108010036039 Serrate-Jagged Proteins Proteins 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 231100000851 acute glomerulonephritis Toxicity 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 208000002205 allergic conjunctivitis Diseases 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000024998 atopic conjunctivitis Diseases 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000012050 conventional carrier Substances 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 235000015140 cultured milk Nutrition 0.000 description 1
- 235000021438 curry Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000019985 fermented beverage Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 235000013332 fish product Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000020510 functional beverage Nutrition 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 210000000224 granular leucocyte Anatomy 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000028996 humoral immune response Effects 0.000 description 1
- 230000007124 immune defense Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000004719 natural immunity Effects 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000013555 soy sauce Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 배 및 생강의 혼합 발효물을 유효성분으로 포함하는 면역 증강용 조성물에 관한 것이다.The present invention relates to a composition for enhancing immunity, which comprises a fermented product of a pear and a ginger as an active ingredient.
면역은 크게, 태어날 때부터 가지고 있는 선천성 면역(innate immunity)과 후천적으로 생활 등에 적응되어 얻어지는 후천성 면역(acquired immunity)로 구분된다. 상기 선천성 면역은 일명 자연면역이라고도 하는 것으로, 항원에 대하여 비특이적으로 반응하며 특별한 기억작용은 보이지 않는다.Immunity is largely divided into the innate immunity that has been born and the acquired immunity which is obtained by adaptation to life and the like. The congenital immunity is also called natural immunity, responds to the antigen nonspecifically, and does not show any special memory effect.
상기 선천성 면역체계로는 항원의 침입을 차단하는 피부, 점액조직, 상산성의 위산, 체내로 들어온 침입자들을 제거하는 식균작용을 담당하는 대식세포(macrophage), 다형핵 백혈구 등과 같은 식세포 등이 있다. 이러한 선천면역은 실제 대부분의 감염을 방어한다. 한편, 후천성 면역은 처음 침입한 항원에 대한 기억작용이 있어, 다시 침입이 발생하였을 때, 특이적으로 반응하여 효과적으로 항원을 제거하는 특징이 있다.Examples of the congenital immune system include skin, mucous tissue, gastric acid, which inhibits the entry of an antigen, macrophages responsible for phagocytosis to remove intruders entering the body, and phagocytes such as polymorphonuclear leukocytes. This congenital immune defenses most infections in practice. On the other hand, acquired immunity has a memory effect on the first infected antigen, and when the infiltration occurs again, it specifically reacts and effectively removes the antigen.
이러한 면역기능이 저하되면, 천식, 계절성 또는 통년성 비염, 알러지성 부비강염, 결막염, 아토피성 피부염, 두드러기, 적혈구의 용혈, 급성 사구체 신염 등 다양한 면역질환이 발생할 수 있다. 이러한 면역질환은 치료보다 예방이 중요한데, 현재 시판되고 있는 치료제는 예방을 위하여 복용하기에는 어려운 것이 현실이다. 이에 부작용의 가능성이 있는 면역증강제의 복용 없이, 면역기능 장애를 예방 및 치료할 수 있는 방법이 요구되어 왔다.When this immune function deteriorates, various immune diseases such as asthma, seasonal or perennial rhinitis, allergic sinusitis, conjunctivitis, atopic dermatitis, urticaria, red blood cell hemolysis, acute glomerulonephritis and the like may occur. Such immune diseases are more important to prevent than treatment, and currently commercial drugs are difficult to take for prevention. There has been a need for a method for preventing and treating immune dysfunction without the use of immunostimulants which have the potential for side effects.
이러한 요구에 따라, 면역기능장애를 예방 및 치료할 수 있는 새로운 약물연구 및 제재개발에 많은 연구가 수행되어 왔으며, 특히 부작용이 적은 천연물에서의 면역증강제 또는 항암물질의 개발에 관한 연구에 관심이 집중되었다.In response to these demands, many studies have been conducted on new drug researches and redevelopments that can prevent and treat immune dysfunction. Particularly, interest has been focused on the development of immunopotentiators or anticancer substances in natural products with few side effects .
상기 면역기능을 증강시키는 면역증강제의 개념은 로만(Roman)에 의해 제시되었으며, 어떠한 면역증강물질을 백신과 함께 투여하면 백신만을 투여한 경우에 비해 백신의 효과가 더 증진되는 것이 밝혀지면서 알려지기 시작하였다. 상기 면역증강제란, 숙주의 특이 또는 비특이, 세포성 및 체액성 면역반응을 상승시키는 모든 물질을 말하는데, 최근 감염이나 종양의 치료에 면역강화가 이용되면서 많은 관심을 불러일으키고 있다.The concept of an immune enhancer enhancing the immune function has been suggested by Roman and it has been shown that administration of any immunopotentiating substance together with the vaccine further enhances the effect of the vaccine as compared with administration of the vaccine alone Respectively. The term immunostimulant refers to any substance which raises the specific or nonspecific, cellular and humoral immune response of the host. Recently, immune enrichment has been used in the treatment of infections and tumors, which has attracted much attention.
본 발명의 목적은 상기와 같은 종래기술의 문제점을 해결하기 위한 것으로서 본 발명은 배 및 생강의 혼합 발효물을 유효성분으로 포함하는 비만 치료, 개선 또는 예방용 조성물을 제공하는 것을 목적으로 한다.It is an object of the present invention to provide a composition for treating, ameliorating or preventing obesity, which comprises a fermented product of ginseng and ginger as an active ingredient.
상기 목적을 달성하기 위하여, 본 발명은 면역 증강용 조성물을 제공한다. 상기 면역 증강용 조성물은 약학 조성물 또는 의약 조성물 일 수 있다. In order to accomplish the above object, the present invention provides a composition for enhancing immunity. The immunoconjugate composition may be a pharmaceutical composition or a pharmaceutical composition.
상기 면역 증강용 조성물은 배 및 생강의 혼합 발효물, 구체적으로 배 및 생강을 각각 분쇄하여 배 분쇄물 및 생강 분쇄물을 제조하는 단계; 상기 배 분쇄물에 설탕을 첨가한 후, 34개월 동안 발효한 뒤, 원심분리하여 발효액을 분리하는 배 발효액 제조 단계; 상기 생강 분쇄물에 설탕을 첨가한 후, 22개월 동안 발효한 뒤, 원심분리하여 발효액을 분리하는 생강 발효액 제조 단계; 및 상기 배 발효액 및 생강 발효액을 혼합액 전체 중량을 기준으로 65중량% : 35중량%(배 : 생강)의 함량으로 혼합하여 배 및 생강의 혼합 발효물을 제조하는 배 및 생강의 혼합 발효물 제조 단계를 포함하는 배 및 생강의 혼합 발효물의 제조방법에 의해 제조된 것을 유효성분으로 포함할 수 있다. Wherein the composition for immunomodulation is prepared by pulverizing a mixed fermented product of a pear and a ginger, specifically a pear and a ginger, respectively, to prepare a pulverized product and a ginger pulverized product; Preparing a fermentation broth by adding sugar to the pulverized product, fermenting the fermented product for 34 months, and then centrifuging to separate the fermentation broth; Preparing ginger fermentation broth by adding sugar to the ginger powder, fermenting the fermented product for 22 months, and then separating the fermentation broth by centrifugation; And mixing the fermentation broth and ginger fermentation broth at a content of 65 wt%: 35 wt% (g: ginger), based on the total weight of the mixture, to prepare a fermented product of ginseng and ginger, And the ginger fermented product of the present invention can be used as an active ingredient.
또한 본 발명은 상기 목적을 달성하기 위하여 면역 증강용 조성물을 제공한다. 상기 면역 증강용 조성물은 식품 조성물 일 수 있다. 상기 식품 조성물은 기능성 식품 조성물 일 수 있다. The present invention also provides a composition for enhancing immunity to achieve the above object. The immunoconjugate composition may be a food composition. The food composition may be a functional food composition.
본 발명의 발명자들은 생체 내 부작용이 없어 장기간 사용할 수 있으며, 면역기능 장애를 예방 및 치료할 수 있는 새로운 면역증강용 조성물를 찾기 위하여 천연 자원으로부터의 소재 개발연구를 계속한 결과, 배 및 생강의 단순 혼합물에 비하여 배 및 생강을 발효한 발효물의 혼합액이 신장 및 흉선의 무게, 백혈구 수의 변화 및 면역 기능과 관련된 인자(Cytokine)인 IL-12, TNF-α 및 INF-γ의 함량을 측정한 결과, 현저하게 우수한 면역활성 개선능을 가지고 있어, 면역증강제로 유용하게 이용할 수 있음을 확인함으로써 본 발명을 완성하였다.The inventors of the present invention have continued research on the development of materials from natural sources in order to find a novel composition for immune enhancement that can be used for a long period of time without any side effects in vivo and can prevent and treat immune dysfunction. As a result, The contents of IL-12, TNF-α and INF-γ, which are the cytokines related to the weight of kidney and thymus, changes in leukocyte count and immune function, were measured by the mixture of fermented broth and ginger fermented product. And thus can be effectively used as an immunostimulating agent. Thus, the present invention has been completed.
본 명세서에서 특별한 언급이 없는 한, 유효성분이란 조성물, 구체적으로 의약 조성물 또는 식품 조성물에 있어서 면역기능 개선 효과를 제공하는 성분을 의미한다.Unless otherwise specified in the present specification, an effective component means a component that provides an immune function improving effect in a composition, specifically, a pharmaceutical composition or a food composition.
본 명세서에서 특별한 언급이 없는 한, 면역질환이란 생체의 면역체계 이상으로 유발되는 다양한 질환을 모두 포함하는 개념이며, 구체적으로, 염증성 질환, 알러지성 질환, 암, 감기, 천식, 폐렴, 알러지성 비염, 알러지성 결막염, 아토피성 피부염, 알러지, 류마티스 관절염, 알츠하이머병, 자가면역성 갑상선 질환, 염증성 장질환, 재생불량성 빈혈, 홍반성 루푸스 및 건선 등을 포함하는 개념이나 이에 제한되는 것은 아니다.
Unless specifically stated herein, an immunological disease is a concept that includes all kinds of diseases caused by an immune system abnormality in a living body. Specifically, the term " immunological disease " includes not only an inflammatory disease, an allergic disease, cancer, cold, asthma, , Allergic conjunctivitis, atopic dermatitis, allergies, rheumatoid arthritis, Alzheimer's disease, autoimmune thyroid disease, inflammatory bowel disease, aplastic anemia, lupus erythematosus and psoriasis.
이하, 본 발명을 더욱 상세하게 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명은 배 및 생강의 혼합 발효물을 유효성분으로 포함하는 면역 증강용 조성물에 관한 것이다. 상기 면역 증강용 조성물은 의약 조성물 또는 약학 조성물 일 수 있다. 구체적으로, 상기 면역 증강용 조성물은 면역질환 예방 또는 치료용 의약 조성물일 수 있다.The present invention relates to a composition for enhancing immunity, which comprises a fermented product of a pear and a ginger as an active ingredient. The immunoconjugate composition may be a pharmaceutical composition or a pharmaceutical composition. Specifically, the immunoconjugate composition may be a pharmaceutical composition for preventing or treating immune diseases.
상기 배(pear)는 배나무의 열매로, 열매 중 먹을 수 있는 부분이 약 80%이고, 수분의 함량이 85% 내지 88%이며, 주성분은 탄수화물이고, 과당 및 자당 등의 당분과, 사과산, 주석산, 시트르산 등의 유기산 외에 비타민 B와 비타민 C 등의 성분과 섬유소, 미네랄 등이 풍부하다. 주로 기관지 질환에 효과가 있으며, 배변과 이뇨작용을 돕는다.The pear is a fruit of a pear, and the portion of the fruit that can be eaten is about 80%, the content of water is 85% to 88%, the main ingredient is a carbohydrate, and the sugar such as fructose and sucrose, , And organic acids such as citric acid, as well as components such as vitamin B and vitamin C, and is rich in fiber and minerals. It is mainly effective against bronchial diseases, and helps defecation and diuretic action.
상기 배나무(Pyrus serotina)는 장미과 배나무속의 나무를 통틀어 이르는 말로, 높이는 2 m 내지 3 m 정도이고, 잎은 달걀 모양으로 톱니가 있으며, 봄에 흰색의 꽃이 주로 세 송이씩 모여서 핀다. 상기 배나무는 이목 또는 이수라고도 불리운다. 야생종으로는 돌배나무, 남해배나무, 야광나무 등이 있고, 최근에 재배되는 품종으로는 신고, 만상길, 황금, 장십랑, 추황, 금촌추, 고실네, 청실네 또는 암니 등이 있다.The pear ( Pyrus) serotina ) is a vernacular word in the rose and pear tree. It is about 2 m to 3 m in height. The leaves are ovate and serrate, and three white flowers bloom in spring. The pear tree is also referred to as a tree or a tree. There are several kinds of wild varieties such as perennials, southern pear, and luminous trees. Recently, cultivated varieties include.
상기 생강(ginger, Zingiber officinale)은 외떡잎식물 생강목 생강과 생강속에 속하는 여러해살이풀로, 새앙 또는 새양이라고도 한다. 동남아시아가 원산지이고 채소로 배재된다. 뿌리줄기는 옆으로 자라고, 다육질이며 덩어리 모양이고 황생이며 매운 맛과 향긋한 냄새가 난다. 뿌리줄기의 각 마디에서 잎집으로 만들어진 가짜 줄기가 곧게 서고, 높이가 30 cm 내지 50 cm에 달하며 윗부분에 잎이 2줄로 배열된다. 잎은 어긋나고 줄 모양의 바소꼴이며 양끝이 좁고 밑 부분이 긴 잎집이 된다. 상기 뿌리줄기는 말려 갈아서 빵, 과장, 카레, 소스 등에 향신료로 사용하고, 껍질을 벗기고 끓인 후 시럽에 넣어 절이기도 하며, 생강차와 생강주 등을 만들기도 한다. 한방에서는 뿌리줄기 말린 것을 건강이라는 약재로 쓰는데, 식욕을 돋워주고, 소화불량, 구토, 설사에 효과가 있으며, 혈액 순환을 촉진하고, 항염증 효과 및 진통 효과가 있는 것으로 알려져 있다.The ginger ( Zingiber officinale ) is a perennial plant belonging to the ginger tree ginger and ginger in the monocotyledonous plant. Southeast Asia is the origin and is distributed as vegetable. The rootstock grows sideways, is fleshy, lumpy, yellowish, and has a pungent flavor and a fragrant smell. At each node of the rootstock, a fake stem made of a sheath is straight, with a height of 30 cm to 50 cm, and two leaves on the top. Leaves are slanted, bar-shaped, with narrow ends on both ends and long bottom leaves. The rootstock is dried and used as a spice for bread, exoskeleton, curry, sauce, peeled, boiled, put in syrup, and made into ginger tea and ginger. In one room, dried roots are used as medicines for health, which stimulates appetite, has effects on digestion, vomiting and diarrhea, promotes blood circulation, and has anti-inflammatory and analgesic effects.
상기 배 및 생강의 혼합 발효물은 상기 배 발효액 및 생강 발효액을 혼합한 것일 수 있고, 바람직하게는 배 및 생강의 혼합 발효물은 배 및 생강을 각각 분쇄하여 배 분쇄물 및 생강 분쇄물을 제조하는 단계; 상기 배 분쇄물에 설탕을 첨가한 후, 34개월 동안 발효한 뒤, 원심분리하여 발효액을 분리하는 배 발효액 제조 단계; 상기 생강 분쇄물에 설탕을 첨가한 후, 22개월 동안 발효한 뒤, 원심분리하여 발효액을 분리하는 생강 발효액 제조 단계; 및 상기 배 발효액 및 생강 발효액을 혼합액 전체 중량을 기준으로 65중량% : 35중량%(배 : 생강)의 함량으로 혼합하여 배 및 생강의 혼합 발효물을 제조하는 배 및 생강의 혼합 발효물 제조 단계를 포함하는 배 및 생강의 혼합 발효물의 제조방법에 의해 제조된 것일 수 있다.The mixed fermented product of the pear and ginger may be a mixture of the fermentation broth and the ginger fermentation broth. Preferably, the mixed fermented product of the pear and ginger is pulverized into a pear and a ginger to prepare a pulverized product and a ginger pulverized product step; Preparing a fermentation broth by adding sugar to the pulverized product, fermenting the fermented product for 34 months, and then centrifuging to separate the fermentation broth; Preparing ginger fermentation broth by adding sugar to the ginger powder, fermenting the fermented product for 22 months, and then separating the fermentation broth by centrifugation; And mixing the fermentation broth and ginger fermentation broth at a content of 65 wt%: 35 wt% (g: ginger), based on the total weight of the mixture, to prepare a fermented product of ginseng and ginger, And a method for producing a fermented product of a ginger and a pear containing ginger.
본 발명의 면역 증강용 의약 조성물은 면역질환 예방 또는 치료용 의약 조성물일 수 있다.The immunoconjugate composition of the present invention may be a pharmaceutical composition for preventing or treating immune diseases.
상기 면역질환은 체내의 면역체계 이상으로 유발되는 질환을 의미하며, 구체적으로 염증성 질환, 알러지성 질환 및 암으로 이루어진 군 중에서 선택된 어느 하나, 더욱 구체적으로 감기, 천식, 폐렴, 알러지성 비염, 알러지성 결막염, 아토피성 피부염, 알러지, 류마티스 관절염, 자가면역성 갑상선 질환, 염증성 장질환, 재생불량성 빈혈, 홍반성 루푸스, 건선 및 암으로 이루어진 군 중에서 선택된 어느 하나일 수 있다.The immunological disease refers to a disease caused by an immune system abnormality in the body, and specifically refers to any one selected from the group consisting of an inflammatory disease, an allergic disease and cancer, more specifically, a cold, asthma, pneumonia, allergic rhinitis, Inflammatory bowel disease, anorexia, conjunctivitis, atopic dermatitis, allergy, rheumatoid arthritis, autoimmune thyroid disease, inflammatory bowel disease, aplastic anemia, lupus erythematosus, psoriasis and cancer.
상기 배 및 생강의 혼합 발효물은 실험동물을 이용하여 실험한 결과, 신장 및 흉선의 무게, 백혈구 수의 변화 및 면역 기능과 관련된 인자(Cytokine)인 IL-12, TNF-α 및 INF-γ의 함량을 측정한 통하여 확인한 결과, 단순히 배 추출물 또는 생강 추출물을 처리한 경우에 비하여, 면역활성 개선능이 우수한 것으로 확인되었다.The mixed fermented product of the ginseng and the ginseng was tested by using an experimental animal. As a result, it was found that the concentration of IL-12, TNF-α and INF-γ, which are cytokines related to the renal and thymus weight, As a result of checking the contents, it was confirmed that the ability to improve the immunological activity was superior to that of the case of simply treating the pear extract or ginger extract.
상기 배 및 생강의 혼합 발효물을 유효성분으로 포함하는 면역 증강용 조성물은 상기 유효성분 외에 추가로 영양제, 비타민, 전해질, 풍미제, 착색제, 중진제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 추가로 포함 할 수 있다.The composition for enhancing immunity comprising the mixed fermented product of the ginger and the ginger may further contain, in addition to the active ingredient, a nutritional supplement, a vitamin, an electrolyte, a flavoring agent, a colorant, a thickening agent, a pectic acid and its salt, Organic acids, protective colloid thickening agents, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated drinks, and the like.
또한, 상기 담체, 부형제 또는 희석제는 락토스, 덱스트로스, 수크로스, 솔비톨, 만니톨, 자이리톨, 에리스리톨, 말티톨, 전분, 아키시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로오스, 메틸 셀룰로오스, 미정질 셀루로오스, 폴리비닐 피롤리돈, 물, 메틸하이드록시벤조에이트, 프로필하이드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유, 덱스트린, 칼슘카보네이드, 프로필렌글리콜, 리퀴드 파라핀, 생리식염수로 이루어진 군에서 선택된 1이상 일 수 있으나, 이에 한정되는 것은 아니며 통상의 담체, 부형제 또는 희석제 모두 사용 가능하다. 상기 성분들은 상기 유효성분 즉, 배 및 생강의 혼합 발효물에 독립적으로 또는 조합하여 추가될 수 있다.The carrier, excipient or diluent may be selected from lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acicia gum, alginate, gelatin, calcium phosphate, calcium silicate, cellulose, methylcellulose, microcrystalline In the group consisting of celluloses, polyvinylpyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil, dextrin, calcium carbonate, propylene glycol, liquid paraffin, But the present invention is not limited thereto. Any conventional carrier, excipient or diluent may be used. The components may be added to the active ingredient, that is, to the mixed fermentation product of the pear and ginger, independently or in combination.
상기 배 및 생강의 혼합 발효물을 유효성분으로 포함하는 면역 증강용 조성물은 조성물 총 중량에 대하여 상기 유효성분을 0.001 중량% 내지 99.9 중량%, 바람직하게는 0.1 중량% 내지 99 중량%, 더욱 바람직하게는 1중량% 내지 50 중량% 포함할 수 있다. 또한, 상기 추가성분의 함량은 상기 면역 증강용 조성물 총 중량에 대하여 0.1 중량% 내지 20 중량% 범위에서 추가할 수 있으나, 이에 한정되는 것은 아니다.The composition for enhancing immunity comprising the mixed fermented product of the above ginger and pear ginger as an active ingredient preferably contains 0.001% by weight to 99.9% by weight, preferably 0.1% by weight to 99% by weight, of the above-mentioned effective ingredient relative to the total weight of the composition, May comprise from 1% to 50% by weight. The content of the additional component may be added in the range of 0.1% by weight to 20% by weight based on the total weight of the immunoconjugating composition, but is not limited thereto.
또한, 상기 배 및 생강의 혼합 발효물을 유효성분으로 포함하는 면역 증강용 조성물을 약제화하는 경우, 통상의 충진제, 증량제, 결합제, 붕해제, 계면활성제, 항응집제, 윤활제, 습윤제, 향료, 유화제 또는 방부제 등을 더욱 포함할 수 있으며, 경구 또는 비경구 모두 사용할 수 있다.In addition, when the composition for enhancing immunity comprising the mixed fermented product of gum and gingiva as an active ingredient is weakened, it is possible to use conventional fillers, extenders, binders, disintegrators, surfactants, anti-coagulants, lubricants, wetting agents, Or preservatives, and may be used either orally or parenterally.
구체적으로, 경구투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 상기 유효성분 즉, 배 및 생강의 혼합 발효물에 적어도 하나 이상의 부형제 예를 들면, 전분, 칼슘카보네이트(calcium carbonate), 수크로스(sucrose) 또는 락토오스(lactose), 젤라틴 등을 섞어 조제된다. 또한, 단순한 부형제 이외에 마그네슘 스테아레이트, 탈크 같은 윤활제들도 사용된다. 경구를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데, 흔히 사용되는 단순희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제 예를 들면, 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다.Specifically, solid preparations for oral administration include tablets, pills, powders, granules, capsules and the like. These solid preparations can be prepared by mixing at least one excipient, for example, Starch, calcium carbonate, sucrose or lactose, gelatin and the like. In addition to simple excipients, lubricants such as magnesium stearate and talc may also be used. Liquid preparations for oral use include suspensions, solutions, emulsions, and syrups. In addition to water and liquid paraffin, which are commonly used simple diluents, various excipients such as wetting agents, sweetening agents, have.
또한, 본 발명의 배 및 생강의 혼합 발효물을 유효성분으로 포함하는 면역 증강용 조성물의 제형은 사용방법에 따라 바람직한 형태일 수 있으며, 특히 포유동물에 투여된 후 활성 성분의 신속, 지속 또는 지연된 방출을 제공할 수 있도록 당업계에 공지된 방법을 채택하여 제형화할 수 있다. 구체적인 제형의 예로는 과립제, 산제, 시럽제, 액제, 현탁제, 정제, 주사제, 주정제, 카타플라스마제(cataplasma), 캅셀제, 연질 또는 경질 젤라틴 캅셀 등이 있다.In addition, the formulation of the composition for enhancing immunity comprising the mixed fermented product of ginseng and gingiva of the present invention as an active ingredient may be in a preferable form depending on the method of use, and in particular, Release by the methods known in the art. Examples of the specific formulations include granules, powders, syrups, liquids, suspensions, tablets, injections, main tablets, cataplasma, capsules, soft or hard gelatin capsules and the like.
더 나아가 본 발명의 배 및 생강의 혼합 발효물을 유효성분으로 포함하는 면역 증강용 조성물은 당해 기술 분야의 공지된 적절한 방법을 사용하여 또는 레밍턴의 문헌(Remington's Pharmaceutical Science(최근판), Mack Publishing Company, Easton PA)에 개시되어 있는 방법을 이용하여 바람직하게 제형화될 수 있다.Further, the composition for enhancing immunity comprising the mixed fermented product of ginseng and ginger of the present invention as an active ingredient can be produced by using a suitable known method in the art or by using the method of Remington ' s Pharmaceutical Science (recent edition), Mack Publishing Company , Easton PA). ≪ / RTI >
본 발명에 따른 배 및 생강의 혼합 발효물을 유효성분으로 포함하는 면역 증강용 조성물의 투여량은, 투여방법, 복용자의 연령, 성별 및 체중, 및 질환의 중증도 등을 고려하여 당업자에 의해 적절하게 선택될 수 있다. 일 예로, 본 발명의 배 및 생강의 혼합 발효물을 유효성분으로 포함하는 면역 증강용 조성물은 상기 유효성분을 기준으로 할 때, 0.0001 mg/kg 내지 1000 mg/kg으로, 보다 효과적이기 위해서는 0.01 mg/kg 내지 500 mg/kg으로 투여할 수 있다. 투여는 하루에 한번 투여할 수도 있고, 수회 나누어 투여할 수도 있다. 상기 투여량은 어떠한 면으로든 본 발명의 범위를 한정하는 것은 아니다.The dose of the composition for enhancing immunity comprising the mixed fermented product of ginseng and ginger according to the present invention as an active ingredient can be suitably adjusted by a person skilled in the art in consideration of the administration method, the age, sex and weight of the recipient, Can be selected. For example, the composition for enhancing immunity comprising the mixed fermented product of ginseng and gingiva of the present invention as an active ingredient may be used in an amount of 0.0001 mg / kg to 1000 mg / kg, / kg to 500 mg / kg. The administration may be carried out once a day or divided into several times. The dose is not intended to limit the scope of the invention in any way.
또한, 본 발명의 배 및 생강의 혼합 발효물을 유효성분으로 포함하는 면역 증강용 조성물은, 상기 유효성분 이외에 공지의 면역 증강 효과를 갖는 화합물 또는 천연물에 대한 추출물을 더욱 포함할 수 있으며, 상기 유효성분 100 중량부에 대하여 각각 5 중량부 내지 200 중량부로 포함될 수 있다.In addition, the composition for enhancing immunity comprising the mixed fermented product of ginseng and gingiva according to the present invention may further comprise a compound having a known immune enhancing effect or an extract for a natural substance in addition to the effective ingredient, And 5 parts by weight to 200 parts by weight with respect to 100 parts by weight of the component.
또한 본 발명은 배 및 생강의 혼합 발효물을 유효성분으로 포함하는 면역 증강용 식품 조성물에 관한 것이다. 상기 식품 조성물은 건강기능식품 조성물 일 수 있다.The present invention also relates to a food composition for enhancing immunity, which comprises a fermented product of a pear and ginger as an active ingredient. The food composition may be a health functional food composition.
상기 배 및 생강의 혼합 발효물은 상기 배 발효액 및 생강 발효액을 혼합한 것일 수 있고, 바람직하게는 배 및 생강의 혼합 발효물은 배 및 생강을 각각 분쇄하여 배 분쇄물 및 생강 분쇄물을 제조하는 단계; 상기 배 분쇄물에 설탕을 첨가한 후, 34개월 동안 발효한 뒤, 원심분리하여 발효액을 분리하는 배 발효액 제조 단계; 상기 생강 분쇄물에 설탕을 첨가한 후, 22개월 동안 발효한 뒤, 원심분리하여 발효액을 분리하는 생강 발효액 제조 단계; 및 상기 배 발효액 및 생강 발효액을 혼합액 전체 중량을 기준으로 65중량% : 35중량%(배 : 생강)의 함량으로 혼합하여 배 및 생강의 혼합 발효물을 제조하는 배 및 생강의 혼합 발효물 제조 단계를 포함하는 배 및 생강의 혼합 발효물의 제조방법에 의해 제조된 것일 수 있다.The mixed fermented product of the pear and ginger may be a mixture of the fermentation broth and the ginger fermentation broth. Preferably, the mixed fermented product of the pear and ginger is pulverized into a pear and a ginger to prepare a pulverized product and a ginger pulverized product step; Preparing a fermentation broth by adding sugar to the pulverized product, fermenting the fermented product for 34 months, and then centrifuging to separate the fermentation broth; Preparing ginger fermentation broth by adding sugar to the ginger powder, fermenting the fermented product for 22 months, and then separating the fermentation broth by centrifugation; And mixing the fermentation broth and ginger fermentation broth at a content of 65 wt%: 35 wt% (g: ginger), based on the total weight of the mixture, to prepare a fermented product of ginseng and ginger, And a method for producing a fermented product of a ginger and a pear containing ginger.
상기 식품이란 영양소를 한 가지 또는 그 이상 함유하고 있는 천연물 또는 가공품을 의미하며, 바람직하게는 어느 정도의 가공 공정을 거쳐 직접 먹을 수 있는 상태가 된 것을 의미하며, 통상적인 의미로서, 건강기능식품, 음료, 식품 첨가제 및 음료 첨가제 등을 모두 포함하는 의도이다.The term " food " means a natural product or a processed product containing one or more nutrients, preferably a state of being able to be eaten directly through a certain degree of processing, Beverages, food additives, beverage additives, and the like.
상기 식품은 예를 들어, 각종 식품류, 음료, 껌, 차, 비타민 복합제, 건강기능식품 등이 있다. 추가로, 본 발명에서 식품에는 특수영양식품(예, 조제유류, 영,유아식 등), 식육가공품, 어육제품, 두부류, 묵류, 면류(예, 라면류, 국수류 등), 건강보조식품, 조미식품(예, 간장, 된장, 고추장, 혼합장 등), 소스류, 과자류(예, 스넥류), 유가공품(예, 발효유, 치즈 등), 기타 가공식품, 김치, 절임식품(각종 김치류, 장아찌 등), 음료(예, 과실,채소류 음료, 두유류, 발효음료류 등), 천연조미료(예, 라면스프 등)을 포함하나 이에 한정되지 않는다. 상기 식품, 건강기능식품, 음료, 식품 첨가제 및 음료 첨가제는 통상의 제조방법으로 제조될 수 있다.Such foods include, for example, various foods, beverages, gums, tea, vitamin complexes, and health functional foods. In addition, in the present invention, the food may contain special nutritional foods (e.g., crude oil, spirits, infant food, etc.), meat products, fish products, tofu, jelly, noodles (Such as soy sauce, soybean paste, hot pepper paste, mixed sauce), sauces, confectionery (eg snacks), dairy products (eg fermented milk, cheese), other processed foods, kimchi, pickled foods But are not limited to, fruits, vegetables, beverages, fermented beverages, etc.), natural seasonings (e.g., ramen soup, etc.). The food, the health functional food, the beverage, the food additive and the beverage additive can be produced by a usual production method.
본 발명에서 건강기능식품이란 식품에 물리적, 생화학적, 생물공학적 수법 등을 이용하여 해당 식품의 기능을 특정 목적에 작용, 발현하도록 부가가치를 부여한 식품군이나 식품 조성이 갖는 생체방어리듬조절, 질병방지와 회복 등에 관한 체중조절기능을 생체에 대하여 충분히 발현하도록 설계하여 가공한 식품을 의미한다.In the present invention, the health functional food refers to a food group imparted with added value to function or express the function of the food by physical, biochemical, biotechnological techniques, etc., or to control the biological defense rhythm of the food composition, Means a food that is designed and manufactured so that the weight control function related to recovery and the like is sufficiently expressed in living bodies.
상기 건강기능식품에는 식품학적으로 허용 가능한 식품 보조 첨가제를 포함할 수 있으며, 건강기능식품의 제조에 통상적으로 사용되는 적절한 담체, 부형제 및 희석제를 더욱 포함할 수 있다.The health functional food may include food-acceptable food supplementary additives, and may further include suitable carriers, excipients and diluents conventionally used in the production of health functional foods.
상기 음료란 갈증을 해소하거나 맛을 즐기기 위하여 마시는 것의 총칭을 의미하며 건강기능음료를 포함하는 의도이다. 상기 음료는 지시된 비율로 필수 성분으로서 상기 배 및 생강의 혼합 발효물을 유효성분으로 포함하는 것 외에 다른 성분에는 특별한 제한이 없으며, 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다.The drink refers to a generic term for eliminating thirst or drinking to enjoy a taste, and is intended to include a health functional drink. The beverage is not particularly limited as long as it contains, as an essential ingredient, a mixed fermented product of the pear and ginger as an active ingredient as the essential ingredient at the indicated ratio, and it is also possible to add various flavors or natural carbohydrates, .
상기의 천연 탄수화물의 예는 모노사카라이드, 예를 들어 포도당, 과당 등 디사카라이드, 예를 들어 말토스, 수크로스 등 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 자일리톨, 소르비톨, 에리트리톨 등의 당알코올이다. 상기한 것 이외의 향미제로서 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진 등) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 식품조성물 100㎖ 당 일반적으로 약 1 내지 20g, 바람직하게는 5 내지 12g일 수 있다. 그밖에 본 발명의 조성물은 천연 과일 주스, 과일 쥬스 음료, 야채 음료의 제조를 위한 과육을 추가로 함유할 수 있다.Examples of such natural carbohydrates include monosaccharides such as disaccharides such as glucose and fructose such as maltose, sucrose and the like and polysaccharides such as dextrins, cyclodextrins and the like, and Xylitol, sorbitol, and erythritol. Natural flavors (tau martin, stevia extract (e.g., rebaudioside A, glycyrrhizin, etc.) and synthetic flavors (saccharin, aspartame, etc.) can be advantageously used as flavors other than those described above The ratio of the natural carbohydrate may be generally about 1 to 20 g, preferably 5 to 12 g per 100 ml of the food composition of the present invention. In addition, the composition of the present invention can be used for the production of natural fruit juice, fruit juice drink, Can also be added.
상기 외에 본 발명의 식품 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산 음료에 사용되는 탄산화제 등을 함유할 수 있다. 이러한 성분을 독립적으로 또는 조합하여 사용할 수 있다. 이러한 첨가제의 비율은 그렇게 중요하지 않지만, 본 발명의 배 및 생강의 혼합 발효물 100 중량부 당 0 내지 2,000 중량부 범위에서 선택될 수 있다.In addition to the above, the food composition of the present invention can be used as a flavoring agent such as a variety of nutrients, vitamins, minerals (electrolytes), synthetic flavors and natural flavors, coloring agents and thickening agents (cheese, chocolate etc.), pectic acid and its salts, Salts thereof, organic acids, protective colloid thickeners, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated drinks, and the like. These components can be used independently or in combination. The ratio of these additives is not so important, but may be selected in the range of 0 to 2,000 parts by weight per 100 parts by weight of the mixed fermented product of the present invention.
상기 건강기능음료란 음료에 물리적, 생화학적, 생물공학적 수법 등을 이용하여 해당 음료의 기능을 특정 목적에 작용, 발현하도록 부가가치를 부여한 음료 군이나 음료 조성이 갖는 생체방어리듬조절, 질병방지와 회복 등에 관한 체조절기능을 생체에 대하여 충분히 발현하도록 설계하여 가공한 음료를 의미한다.The health-functional beverage is used to control the bio-defense rhythm of the beverage group or beverage composition to which the added value is imparted so that the function of the beverage functions for a specific purpose by physical, biochemical, biotechnological, or the like, Means a beverage which has been designed so as to sufficiently express the body controlling function related to the living body.
상기 건강기능음료는 지시된 비율로 필수 성분으로서 본 발명의 배 및 생강의 혼합 발효물을 함유하는 외에는 다른 성분에는 특별한 제한이 없으며 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다.The health functional beverage is not particularly limited as long as it contains the fermented product of the present invention and the mixed fermented product of ginger as an essential ingredient at the indicated ratio, and may be added with various flavors or natural carbohydrates, ≪ / RTI >
상기 천연 탄수화물의 예는 모노사카라이드, 예를 들어 포도당, 과당 등 디사카라이드, 예를 들어 말토스, 수크로스 등 및 폴리사카라이드, 예를 들어 덱스트린, 시클로덱스트린 등과 같은 통상적인 당, 및 자일리톨, 소르비톨, 에리트리톨 등의 당알코올이다. 상기한 것 이외의 향미제로서 천연 향미제(타우마틴, 스테비아 추출물(예를 들어 레바우디오시드 A, 글리시르히진 등) 및 합성 향미제(사카린, 아스파르탐 등)를 유리하게 사용할 수 있다. 상기 천연 탄수화물의 비율은 본 발명의 조성물 100 ㎖ 당 일반적으로 약 1 g 내지 20 g, 바람직하게는 5 g 내지 12 g이다.Examples of such natural carbohydrates include monosaccharides such as disaccharides such as glucose and fructose such as maltose, sucrose and the like and polysaccharides such as dextrins, cyclodextrins and the like, and xylitol , Sorbitol, and erythritol. Natural flavors (tau martin, stevia extract (e.g., rebaudioside A, glycyrrhizin, etc.) and synthetic flavors (saccharin, aspartame, etc.) can be advantageously used as flavors other than those described above The ratio of the natural carbohydrate is generally about 1 to 20 g, preferably 5 to 12 g per 100 ml of the composition of the present invention.
또한, 배 및 생강의 혼합 발효물을 유효성분으로 포함하는 비만 예방 또는 개선용 식품 조성물에 있어서, 상기 유효성분은 전체 식품 중량의 0.01 중량% 내지 15 중량%로 포함될 수 있으며, 음료 조성물은 100 ㎖를 기준으로 0.02 g 내지 5 g, 바람직하게는 0.3 g 내지 1 g의 비율로 포함될 수 있다.In addition, in the food composition for preventing or improving obesity, which comprises a fermented product of a mixture of pear and ginger as an active ingredient, the effective ingredient may be contained in an amount of 0.01 to 15% by weight of the total food, 0.0 > g < / RTI > to 5 g, preferably 0.3 g to 1 g.
본 발명의 유효성분인 배 및 생강의 혼합 발효물은 단순히 배 또는 생강을 처리한 것에 비하여, 신장 및 흉선의 무게, 백혈구 수의 변화 및 면역 기능과 관련된 인자(Cytokine)인 IL-12, TNF-α 및 INF-γ의 함량을 측정한 통하여 확인한 결과 면역증강능이 우수한 것으로 확인되었다. 또한, 상기 배 및 생강은 식용으로 오랜기간 사용된 것이므로, 안전성도 우수하고, 부작용의 문제가 발생되지 아니하므로, 면역증강과 관련된 의약조성물 또는 식물조성물로 널리 사용할 수 있어, 식품산업 및 의약산업 분야에서 산업적 효과가 뛰어난 것으로 인정된다.The mixed fermented product of ginseng and ginseng, which is an effective ingredient of the present invention, is more effective than a simple fermented product of ginseng or ginger, in comparison with the cytokines IL-12, TNF- α and IFN-γ, respectively, were found to be excellent in immunostimulating ability. In addition, since the pear and ginger have been used for a long period of time, they are excellent in safety and do not cause side effects, so they can be widely used as a pharmaceutical composition or a plant composition related to immunity enhancement, Is recognized as having excellent industrial effect.
이하, 본 발명이 속하는 기술 분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있도록 본 발명의 실시예에 대하여 상세히 설명한다. 그러나 본 발명은 여러 가지 상이한 형태로 구현될 수 있으며 여기에서 설명하는 실시예에 한정되지 않는다.
Hereinafter, embodiments of the present invention will be described in detail so that those skilled in the art can easily carry out the present invention. The present invention may, however, be embodied in many different forms and should not be construed as limited to the embodiments set forth herein.
실시예Example . 배 및 생강의 혼합 . Mix of pear and ginger 발효물의Fermented 제조 Produce
배 및 생강의 혼합 발효물은 다음과 같은 방법으로 제조하였다.The mixed fermented product of pear and ginger was prepared as follows.
우선, 배는 전남 나주지역에서 재배된 배를 2011년 11월 4일자에 구입하였고, 생강은 전북 전주지역에서 재배된 생강을 2011년 11월 8일자에 구입하였다. 상기 각각 구입한 배 및 생각은 개별적으로 유수에서 깨끗이 세척한 후, 분쇄기(Nisshin ryoki model-75, 일본)를 이용하여 잘게 분쇄하였다. 상기 각각 분쇄된 배 분쇄물 26.5 kg 및 생강 분쇄물 26.5 kg을 각각 발효조인 항아리에 집어넣은 후, 갈색설탕(㈜삼양사, 대한민국)을 23.5 kg 집어넣고, 5.8℃ 내지 29.4℃의 온도조건과 절대습도 35% 내지 95%의 습도조건을 유지하면서 배의 경우, 34개월 동안, 생강의 경우 22개월 동안 발효를 진행하였다.First, the pear was purchased on Nov. 4, 2011, and the ginger was purchased on Nov. 8, 2011 in Jeonju, Jeonju region. Each of the purchased vessels and ideas was separately cleaned in running water and finely pulverized using a pulverizer (Nisshin ryoki model-75, Japan). 26.5 kg of each pulverized pulverized product and 26.5 kg of ginger powder were put into a fermenter jar and 23.5 kg of brown sugar (Samyang Co., Ltd., Korea) was poured in. Then, the temperature condition of 5.8 ° C to 29.4 ° C and absolute humidity Fermentation was carried out for 34 months in the case of boats and 22 months in the case of ginger while maintaining the humidity condition of 35% to 95%.
상기 발효기간 동안, 발효시작일로부터 발효시작일 후 2개월이 경과할 때까지는 주 3회, 발효시작일 후 3개월째부터 6개월까지는 월 2회, 발효시작일부터 6개월이 경과된 때부터는 월 1회 작업자가 인위적으로 전체 발효물을 교반시켰다.During the fermentation period, once a month from the start of fermentation until two months after the start of fermentation, three times a week, from three months after the start of fermentation to six months, twice a month, and six months from the start of fermentation, Was artificially stirred with the whole fermentation product.
상기 각각의 발효기간이 경과한 후, 원심추출기(탈수형 3마력 원심추출기, ㈜유성, 대한민국)를 이용하여 발효액을 수집한 후, 각각 저장탱크(2톤 스테인레스스틸 용기, ㈜한성에프앤씨, 대한민국)에 보관하였으며, 2개월 경과 후 각각 제조된 배 발효액과 생강 발효액을 배 6.5 kg 및 생강 3.5 kg 씩 혼합하여 배 및 생강의 혼합 발효액을 제조하였다.
After each fermentation period elapsed, the fermentation broth was collected using a centrifugal extractor (dehydrated 3 horsepower centrifugal extractor, Yuseong, Korea) and stored in a storage tank (2 ton stainless steel vessel, Hansung Ef & . After 2 months, the mixed fermented broth and ginger were prepared by mixing 6.5 kg of ginger fermentation broth and 3.5 kg of ginger, respectively.
이상에서 본 발명의 바람직한 실시예에 대하여 상세하게 설명하였지만 본 발명의 권리범위는 이에 한정되는 것은 아니고 다음의 청구범위에서 정의하고 있는 본 발명의 기본 개념을 이용한 당업자의 여러 변형 및 개량 형태 또한 본 발명의 권리범위에 속하는 것이다.While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed exemplary embodiments, Of the right.
Claims (5)
상기 배 및 생강의 혼합 발효물은 배 및 생강을 각각 분쇄하여 배 분쇄물 및 생강 분쇄물을 제조하는 단계; 상기 배 분쇄물에 설탕을 첨가한 후, 34개월 동안 발효한 뒤, 원심분리하여 발효액을 분리하는 배 발효액 제조 단계; 상기 생강 분쇄물에 설탕을 첨가한 후, 22개월 동안 발효한 뒤, 원심분리하여 발효액을 분리하는 생강 발효액 제조 단계; 및 상기 배 발효액 및 생강 발효액을 혼합액 전체 중량을 기준으로 65중량% : 35중량%(배 : 생강)의 함량으로 혼합하여 배 및 생강의 혼합 발효물을 제조하는 배 및 생강의 혼합 발효물 제조 단계를 포함하는 배 및 생강의 혼합 발효물의 제조방법에 의해 제조된 것인 면역 증강용 의약 조성물.The method according to claim 1,
Wherein the mixed fermented product of the pear and ginger is prepared by pulverizing a pear and a ginger to produce a pear pulverized product and a ginger pulverized product; Preparing a fermentation broth by adding sugar to the pulverized product, fermenting the fermented product for 34 months, and then centrifuging to separate the fermentation broth; Preparing ginger fermentation broth by adding sugar to the ginger powder, fermenting the fermented product for 22 months, and then separating the fermentation broth by centrifugation; And mixing the fermentation broth and ginger fermentation broth at a content of 65 wt%: 35 wt% (g: ginger), based on the total weight of the mixture, to prepare a fermented product of ginseng and ginger, And a fermented product of a mixture of ginger and a ginger comprising the ginger.
상기 배 및 생강의 혼합 발효물은 배 및 생강을 각각 분쇄하여 배 분쇄물 및 생강 분쇄물을 제조하는 단계; 상기 배 분쇄물에 설탕을 첨가한 후, 34개월 동안 발효한 뒤, 원심분리하여 발효액을 분리하는 배 발효액 제조 단계; 상기 생강 분쇄물에 설탕을 첨가한 후, 22개월 동안 발효한 뒤, 원심분리하여 발효액을 분리하는 생강 발효액 제조 단계; 및 상기 배 발효액 및 생강 발효액을 혼합액 전체 중량을 기준으로 65중량% : 35중량%(배 : 생강)의 함량으로 혼합하여 배 및 생강의 혼합 발효물을 제조하는 배 및 생강의 혼합 발효물 제조 단계를 포함하는 배 및 생강의 혼합 발효물의 제조방법에 의해 제조된 것인 면역 증강용 식품 조성물.The method of claim 3,
Wherein the mixed fermented product of the pear and ginger is prepared by pulverizing a pear and a ginger to produce a pear pulverized product and a ginger pulverized product; Preparing a fermentation broth by adding sugar to the pulverized product, fermenting the fermented product for 34 months, and then centrifuging to separate the fermentation broth; Preparing ginger fermentation broth by adding sugar to the ginger powder, fermenting the fermented product for 22 months, and then separating the fermentation broth by centrifugation; And mixing the fermentation broth and ginger fermentation broth at a content of 65 wt%: 35 wt% (g: ginger), based on the total weight of the mixture, to prepare a fermented product of ginseng and ginger, And a fermented product of a mixture of ginger and a ginger comprising the fermented product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140017423A KR20150096237A (en) | 2014-02-14 | 2014-02-14 | Composition containing fermented material of pear and ginger for immune activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020140017423A KR20150096237A (en) | 2014-02-14 | 2014-02-14 | Composition containing fermented material of pear and ginger for immune activity |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20150096237A true KR20150096237A (en) | 2015-08-24 |
Family
ID=54058786
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020140017423A KR20150096237A (en) | 2014-02-14 | 2014-02-14 | Composition containing fermented material of pear and ginger for immune activity |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20150096237A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022131776A1 (en) * | 2020-12-16 | 2022-06-23 | 김남국 | Composition for preventing or treating colitis, comprising pyrus ussuriensis extract or pyrus ussuriensis fermentation product as active ingredient |
-
2014
- 2014-02-14 KR KR1020140017423A patent/KR20150096237A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022131776A1 (en) * | 2020-12-16 | 2022-06-23 | 김남국 | Composition for preventing or treating colitis, comprising pyrus ussuriensis extract or pyrus ussuriensis fermentation product as active ingredient |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2007252785A1 (en) | Guava leaf extract powder and method for production thereof | |
KR101490786B1 (en) | Composition comprising water extracts from fomitella fraxinea (fr.) imaz. for treating or preventing obesity | |
JP2017141199A (en) | Liver function improver | |
CN103125941A (en) | Chinese magnoliavine fruit leavening product, Chinese magnoliavine fruit and ginseng leavening product and application thereof | |
JP5961329B1 (en) | Eating and drinking composition | |
KR101929350B1 (en) | Composition for removing hangover comprising an extract of Allium hookeri | |
KR101720051B1 (en) | Pharmaceutical composition comprising fermented Aralia cordata Thunb for preventing or treating arthritis | |
KR101671961B1 (en) | Manufacturing method of akebia quinata extract and functional food using the same | |
KR20180098888A (en) | Composition for increasing immunity having extract of peanut sprouts extract as active component | |
KR101494664B1 (en) | fermented corni fructus composition with antioxidant activity and method of making the same | |
KR20180042936A (en) | a composition comprising the mycelium culture medium from Schizophyllum commune as an active ingredient for preventing or treating liver disease and alleviating hangover | |
KR20140105657A (en) | A comprising an extracts of fermented Schisandra chinensis Baillon showing anti-oxidative, anti-hypertensive activity | |
JP2019176882A (en) | Beverage | |
KR20160122423A (en) | Composition comprising steamed and fermented Lycium chinense extract with increased anti-inflammatory or antioxidant activity and preparation method thereof | |
JP6872699B2 (en) | Composition for promoting calcium absorption | |
KR20150096237A (en) | Composition containing fermented material of pear and ginger for immune activity | |
JP6541047B1 (en) | Oral composition | |
JP2017165686A (en) | Liver function improver | |
JP6044944B2 (en) | Process for producing new processed ume products and functional composition, food composition, and pharmaceutical composition using the same | |
KR20210155901A (en) | Composition for enhancing immunity comprising NueDongChungHaCho(Paecilomyces tenuipes) water extract | |
KR101490794B1 (en) | Composition comprising alcohol extracts from oligoporus tephroleucus for treating or preventing hyperlipidemia | |
KR101594649B1 (en) | Composition comprising alcohol extracts from ramaria stricta for treating or preventing hyperlipidemia | |
KR101338532B1 (en) | Composition for preventing or treating colon cancer containing extract of sea cucumber | |
JP2011051901A (en) | alpha-GLUCOSIDASE INHIBITOR | |
KR20170028636A (en) | Composition for removing hangover comprising an extract of Allium hookeri |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WITN | Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid |